Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

NLS Pharmaceutics AG's (NLSP) stock saw a notable increase of 29.79 percent, during Friday morning trading. This surge follows the ...

NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage cell therapy company specializing in the treatment of neurodegenerative diseases and ...

NLS Pharmaceutics AG’s profitability metrics reveal strong financial health. The company currently boasts a gross margin of -71.63%. The profit margin, also known as the revenue ratio or gross profit ...

NLS Pharmaceutics stock is trading higher on Friday after the company announced its merger with Kadimastem has been approved by Kadimastem shareholders.

Shareholders of the Israeli bio-pharmaceutical startup, Kadimastem Ltd. approved the company’s merger with the Swiss ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

ZURICH, Jan. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company ...

Joe Sabag, who served as special counsel to Adam Hasner when hasner was majority leader of the Florida House of ...

With a plan to expand its pharmaceutical solutions arm, St. Pete-based engineering and manufacturing giant Jabil recently secured a deal to acquire Pharmaceutics International Inc.